(Tromsø 17. August 2018) Rolf E. Engstad, CSO of Biotec BetaGlucans has purchased 20 000 shares in Biotec Pharmacon at NOK 4.99 per share. After this transaction holds Engstad 430.774 shares and 40.000 options in Biotec Pharmacon
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no
This information was brought to you by Cision http://news.cision.com